• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中miR-29b-1/miR-29a簇多态性的发现及其功能意义

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

作者信息

Ngankeu Apollinaire, Ranganathan Parvathi, Havelange Violaine, Nicolet Deedra, Volinia Stefano, Powell Bayard L, Kolitz Jonathan E, Uy Geoffrey L, Stone Richard M, Kornblau Steven M, Andreeff Michael, Croce Carlo M, Bloomfield Clara D, Garzon Ramiro

机构信息

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

Hematological Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

出版信息

Oncotarget. 2017 Dec 12;9(4):4354-4365. doi: 10.18632/oncotarget.23150. eCollection 2018 Jan 12.

DOI:10.18632/oncotarget.23150
PMID:29435107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5796978/
Abstract

We previously reported that microRNA (miR)-29b is down-regulated and has a tumor suppressor role in acute myeloid leukemia (AML). However, little is known about the mechanisms responsible for miR-29b expression downregulation in AML. In this work we screened for mutations that could affect miR-29b expression. Using Sanger sequencing, we identified a germline thymidine (T) base deletion within the miR-29b-1/miR-29a cluster precursor in 16% of AML patients. Remarkably we found a significant enrichment for the presence of the miR-29 polymorphism in core binding factor (CBF) newly diagnosed AML patients ( = 61/303; 20%) with respect to age, sex and race matched controls ( = 43/402:11%, < 0.01). Mechanistically, this polymorphism affects the expression ratio of mature miR-29b and miR-29a by dampening the processing of miR-29a. RNA immunoprecipitation assays showed reduced DROSHA binding capacity to the polymorphism with respect to the controls. Finally, we showed that this polymorphism negatively impacts the ability of miR-29b-1/miR-29a cluster to target and , both known miR-29 targets.

摘要

我们之前报道过,微小RNA(miR)-29b在急性髓系白血病(AML)中表达下调并具有肿瘤抑制作用。然而,关于AML中miR-29b表达下调的机制知之甚少。在这项研究中,我们筛选了可能影响miR-29b表达的突变。通过桑格测序,我们在16%的AML患者中发现了miR-29b-1/miR-29a簇前体中的一个种系胸腺嘧啶(T)碱基缺失。值得注意的是,我们发现与年龄、性别和种族匹配的对照组相比,新诊断的核心结合因子(CBF)AML患者(n = 61/303;20%)中miR-29多态性的存在显著富集(n = 43/402:11%,P < 0.01)。从机制上讲,这种多态性通过抑制miR-29a的加工来影响成熟miR-29b和miR-29a的表达比例。RNA免疫沉淀分析显示,与对照组相比,DROSHA与该多态性的结合能力降低。最后,我们表明这种多态性对miR-29b-1/miR-29a簇靶向两个已知的miR-29靶点ETS1和RUNX的能力产生负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/e8efc3022b94/oncotarget-09-4354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/be22ec78fd49/oncotarget-09-4354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/fc6b501df4d3/oncotarget-09-4354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/e8efc3022b94/oncotarget-09-4354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/be22ec78fd49/oncotarget-09-4354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/fc6b501df4d3/oncotarget-09-4354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3960/5796978/e8efc3022b94/oncotarget-09-4354-g003.jpg

相似文献

1
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.急性髓系白血病中miR-29b-1/miR-29a簇多态性的发现及其功能意义
Oncotarget. 2017 Dec 12;9(4):4354-4365. doi: 10.18632/oncotarget.23150. eCollection 2018 Jan 12.
2
Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.miR-29a、miR-29b 及其靶基因在髓系白血病中的表达模式改变。
Exp Hematol Oncol. 2014 Jul 1;3:17. doi: 10.1186/2162-3619-3-17. eCollection 2014.
3
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.转铁蛋白修饰的阴离子脂多糖纳米载体靶向递送 miR-29b:急性髓系白血病的一种新治疗策略。
Clin Cancer Res. 2013 May 1;19(9):2355-67. doi: 10.1158/1078-0432.CCR-12-3191. Epub 2013 Mar 14.
4
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.EZH2的抑制触发了多发性骨髓瘤中的肿瘤抑制性miR-29b网络。
Oncotarget. 2017 Nov 20;8(63):106527-106537. doi: 10.18632/oncotarget.22507. eCollection 2017 Dec 5.
5
MicroRNA 29b functions in acute myeloid leukemia.miRNA 29b 在急性髓细胞白血病中发挥作用。
Blood. 2009 Dec 17;114(26):5331-41. doi: 10.1182/blood-2009-03-211938. Epub 2009 Oct 22.
6
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML.抑瘤 miR-29a/b1 簇受 CEBPA 调控并在人 AML 中受阻。
Br J Cancer. 2010 Jul 13;103(2):275-84. doi: 10.1038/sj.bjc.6605751.
7
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.CHO-K1细胞中miR-29b-1/a转录的调控及靶mRNA的鉴定
Mol Cell Endocrinol. 2017 Mar 15;444:38-47. doi: 10.1016/j.mce.2017.01.044. Epub 2017 Jan 28.
8
Expression of PVT-1 and miR-29a/29b as reliable biomarkers for liver cirrhosis and their correlation with the inflammatory biomarkers profile.PVT-1 和 miR-29a/29b 的表达作为肝硬化可靠的生物标志物及其与炎症生物标志物谱的相关性。
Hum Exp Toxicol. 2024 Jan-Dec;43:9603271241251451. doi: 10.1177/09603271241251451.
9
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.他莫昔芬根据乳腺癌细胞的内分泌敏感性差异调节miR-29b-1和miR-29a的表达。
Cancer Lett. 2017 Mar 1;388:230-238. doi: 10.1016/j.canlet.2016.12.007. Epub 2016 Dec 13.
10
Reduced mir-29b-3p expression up-regulate CDK6 and contributes to IgA nephropathy.miR-29b-3p表达降低会上调细胞周期蛋白依赖性激酶6(CDK6)并导致IgA肾病。
Int J Clin Exp Med. 2014 Dec 15;7(12):5275-81. eCollection 2014.

引用本文的文献

1
Role of MicroRNAs in Acute Myeloid Leukemia.微小RNA在急性髓系白血病中的作用
Genes (Basel). 2025 Apr 11;16(4):446. doi: 10.3390/genes16040446.
2
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.颗粒蛋白前体病:与颗粒蛋白失衡相关的多种疾病领域。
Cytokine Growth Factor Rev. 2024 Apr;76:142-159. doi: 10.1016/j.cytogfr.2023.11.001. Epub 2023 Nov 11.
3
MicroRNAs in Leukemias: A Clinically Annotated Compendium.白血病中的 microRNAs:临床注释综合资源库。

本文引用的文献

1
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
2
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.慢性淋巴细胞白血病中 miR-15a/16-1 簇的等位基因特异性缺失和转录。
Leukemia. 2015 Jan;29(1):86-95. doi: 10.1038/leu.2014.139. Epub 2014 Apr 15.
3
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.miR-155 上调可独立鉴定出高危患者:miRNAs 在细胞遗传学正常的急性髓细胞白血病中的临床作用
Int J Mol Sci. 2022 Mar 23;23(7):3469. doi: 10.3390/ijms23073469.
4
miR-484: A Potential Biomarker in Health and Disease.微小RNA-484:健康与疾病中的一种潜在生物标志物。
Front Oncol. 2022 Mar 9;12:830420. doi: 10.3389/fonc.2022.830420. eCollection 2022.
5
Small Non-Coding RNAs in Leukemia.白血病中的小非编码RNA
Cancers (Basel). 2022 Jan 20;14(3):509. doi: 10.3390/cancers14030509.
6
A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.作为生物标志物的微小RNA以及饮食调节对肥胖相关认知衰退和神经退行性疾病的影响综述
Front Mol Neurosci. 2021 Oct 7;14:756499. doi: 10.3389/fnmol.2021.756499. eCollection 2021.
7
MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.与急性髓系白血病预后良好相关的 microRNAs 及其对巨噬细胞极化的影响。
Front Immunol. 2021 Jan 15;11:582915. doi: 10.3389/fimmu.2020.582915. eCollection 2020.
8
The role of noncoding RNAs in epithelial cancer.非编码RNA在上皮性癌中的作用。
Cell Death Discov. 2020 Mar 12;6:13. doi: 10.1038/s41420-020-0247-6. eCollection 2020.
9
MicroRNAs in Autoimmunity and Hematological Malignancies.微小 RNA 在自身免疫和血液系统恶性肿瘤中的作用。
Int J Mol Sci. 2018 Oct 12;19(10):3139. doi: 10.3390/ijms19103139.
J Clin Oncol. 2013 Jun 10;31(17):2086-93. doi: 10.1200/JCO.2012.45.6228. Epub 2013 May 6.
4
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.急性髓系白血病中综合基因分析的预后相关性。
N Engl J Med. 2012 Mar 22;366(12):1079-89. doi: 10.1056/NEJMoa1112304. Epub 2012 Mar 14.
5
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.miR-181a 单一表达在细胞遗传学正常的急性髓细胞白血病中的预后意义:癌症和白血病组 B 的研究。
J Clin Oncol. 2010 Dec 20;28(36):5257-64. doi: 10.1200/JCO.2010.29.2953. Epub 2010 Nov 15.
6
Targeting microRNAs in cancer: rationale, strategies and challenges.靶向癌症中的 microRNAs:原理、策略和挑战。
Nat Rev Drug Discov. 2010 Oct;9(10):775-89. doi: 10.1038/nrd3179.
7
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.KIT 驱动的髓性白血病中的 Sp1/NFkappaB/HDAC/miR-29b 调控网络。
Cancer Cell. 2010 Apr 13;17(4):333-47. doi: 10.1016/j.ccr.2010.03.008.
8
MicroRNA 29b functions in acute myeloid leukemia.miRNA 29b 在急性髓细胞白血病中发挥作用。
Blood. 2009 Dec 17;114(26):5331-41. doi: 10.1182/blood-2009-03-211938. Epub 2009 Oct 22.
9
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.骨骼肌生成和横纹肌肉瘤中的NF-κB-YY1-miR-29调控回路
Cancer Cell. 2008 Nov 4;14(5):369-81. doi: 10.1016/j.ccr.2008.10.006.
10
MicroRNA expression in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中的微小RNA表达
N Engl J Med. 2008 May 1;358(18):1919-28. doi: 10.1056/NEJMoa074256.